Alternatives to Omec.ai

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-driven platform for protein-level disease mapping and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.